Filing Details

Accession Number:
0001209191-23-006215
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-02 16:18:08
Reporting Period:
2023-01-31
Accepted Time:
2023-02-02 16:18:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1829069 Bastiano Sanna C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Cell & Genetic Therapies No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-31 106 $325.00 37,998 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1.